Impact assessment of [18F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based correction of semi-quantitative and volume-based PET metrics.

doi:10.1055/a-2777-2278

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Impact assessment of [18F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based correction of semi-quantitative and volume-based PET metrics.

Nuklearmedizin. Nuclear medicine - 1 Jun 2026

Leontev Aleksei, Lokhova Angelina, Khalimon Aleksandr, Khodzhibekova Malika, Lazutina Tatyana, Khamadeeva Gulnara, Khodakova Daria, Pylova Irina, Bobrov Vitaly, Atakishieva Leila, Kadymova Natalia, Nikiforuk Anastasia, Shvets Bogdan, Volchenko Nadezhda, Surkova Viktoriya, Shatalov Petr, Kaprin Andrey

Abstract excerpt

Aim: The aim of this study was to assess the impact of [18F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based (RC-based) correction of semi-quantitative and volume-based PET metrics. Methods: A retrospective multi-center study included 63 patients diagnosed with lung adenocarcinoma who underwent [18F]FDG PET/CT. Acquisition was performed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Adenocarcinoma of Lung

Share to Aged

Share to ErbB Receptors

Share to Fluorodeoxyglucose F18

Share to Lung Neoplasms

Share to Positron Emission Tomography Computed Tomography

Share to Radiopharmaceuticals

Source

Open in PubMed Open full text

Identifiers

PMID: 41974183
DOI: 10.1055/a-2777-2278
PMCID: PMC13288398

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact assessment of [18F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based correction of semi-quantitative and volume-based PET metrics.PMID 41974183Read ↗

A Predictive Model of EGFR Mutation Status in Patients with Lung Adenocarcinoma Based on PET/CT Metabolic Indexes and Clinicopathological VariablesSemantic proximity Read ↗

Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.Semantic proximity Read ↗

The role of metabolic tumor volume (MTV) measured by [18F] FDG PET/CT in predicting EGFR gene mutation status in non-small cell lung cancer.Semantic proximity Read ↗

The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.Semantic proximity Read ↗

Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metricsSemantic proximity Read ↗

The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutationsSemantic proximity Read ↗

[Evaluate the value of (18)F-FDG PET-CT imaging in predicting the mutationsin epidermal growth factor receptor in lung adenocarcinoma].Semantic proximity Read ↗

Prediction model based on 18F-FDG PET/CT radiomic features and clinical factors of EGFR mutations in lung adenocarcinoma.Semantic proximity Read ↗

Application value of CT radiomic nomogram in predicting T790M mutation of lung adenocarcinoma.Semantic proximity Read ↗

Computed Tomography-derived intratumoral and peritumoral radiomics in predicting EGFR mutation in lung adenocarcinoma.Semantic proximity Read ↗

Comparison of a radiomic biomarker with volumetric analysis for decoding tumour phenotypes of lung adenocarcinoma with different disease-specific survival.Semantic proximity Read ↗

CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.